Cost-of-illness study for non-small-cell lung cancer using real-world data

Por Seung, S.J., Hurry, M., Hassan, S., Walton, R.N., Evans, W.K.
Publicado no Curr Oncol (2019)

Use of targeted therapy in patients with metastatic renal cell carcinoma: clinical and economic impact in a Canadian real-life setting

Por Nazha, S., Tanguay, S., Kapoor, A., Jewett, M., Kollmannsberger, C., Wood, L., Bjarnason, G., Heng, D., Soulières, D., Reaume, N., Basappa, N., Lévesque, E., Dragomir, A.
Publicado no Curr Oncol (2018)

Do patient access schemes for high-cost cancer drugs deliver value to society?—lessons from the NHS Cancer Drugs Fund

Por Aggarwal, A., Fojo, T., Chamberlain, C., Davis, C., Sullivan, R.
Publicado no Ann Oncol (2017)

Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice

Por Calcagno, Fabien, Lenoble, Sabrina, Lakkis, Zaher, Nguyen, Thierry, Limat, Samuel, Borg, Christophe, Jary, Marine, Kim, Stefano, Nerich, Virginie
Publicado no Clin Med Insights Oncol (2016)

How effective is video consultation in clinical oncology? A systematic review

Por Kitamura, C., Zurawel–Balaura, L., Wong, R.K.S.
Publicado em 2010

Evaluation of a Smartphone-Based Training Strategy Among Health Care Workers Screening for Cervical Cancer in Northern Tanzania: The Kilimanjaro Method

Por Yeates, Karen E., Sleeth, Jessica, Hopman, Wilma, Ginsburg, Ophira, Heus, Katharine, Andrews, Linda, Giattas, Mary Rose, Yuma, Safina, Macheku, Godwin, Msuya, Aziz, Oneko, Olola
Publicado no J Glob Oncol (2016)

A Pilot Study to Evaluate the Feasibility of the Image-Guided Breast Conserving Surgery in the Advanced Multimodality Image Guided Operating Suite (AMIGO)

Por Golshan, Mehra, Sagara, Yasuaki, Wexelman, Barbara, Aydogan, Fatih, Desantis, Stephen, Min, H. Elise, Vosburgh, Kirby, Jagadeesan, Jayender, Caragacianu, Diana, Gombos, Eva, Jolesz, Ferenc Andras
Publicado no Ann Surg Oncol (2014)

Clinical investigation of EGFR mutation detection by pyrosequencing in lung cancer patients

Por KIM, HEE JOUNG, OH, SEO YOUNG, KIM, WAN SEOP, KIM, SUN JONG, YOO, GWANG HA, KIM, WON DONG, LEE, KYE YOUNG
Publicado em 2013

Salient concerns in using analgesia for cancer pain among outpatients: A cluster analysis study

Por Meghani, Salimah H, Knafl, George J
Publicado no World J Clin Oncol (2017)

Innovative Strategies for Decreasing Blood Collection Wait Times for Patients in Early-Phase Cancer Clinical Trials

Por Mengistu, Bayabel, Ray, Dina, Lockett, Passion, Dorsey, Vivian, Phipps, Ron A., Subramanian, Harihara, Atkins, Johnique T., El Osta, Badi, Falchook, Gerald S., Karp, Daniel D.
Publicado no J Oncol Pract (2016)

Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma

Por Bale, Tejus A, Jordan, Justin T, Rapalino, Otto, Ramamurthy, Nisha, Jessop, Nicholas, DeWitt, John C, Nardi, Valentina, Alvarez, Maria Martinez-Lage, Frosch, Matthew, Batchelor, Tracy T, Louis, David N, Iafrate, A John, Cahill, Daniel P, Lennerz, Jochen K
Publicado no Neuro Oncol (2019)

Clinical Cancer Advances 2008: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology

Por Winer, Eric, Gralow, Julie, Diller, Lisa, Karlan, Beth, Loehrer, Patrick, Pierce, Lori, Demetri, George, Ganz, Patricia, Kramer, Barnett, Kris, Mark, Markman, Maurie, Mayer, Robert, Pfister, David, Raghavan, Derek, Ramsey, Scott, Reaman, Gregory, Sandler, Howard, Sawaya, Raymond, Schuchter, Lynn, Sweetenham, John, Vahdat, Linda, Schilsky, Richard L.
Publicado em 2009

HOUT-29. HEALTHCARE COSTS FOR HIGH-GRADE GLIOMAS: A POPULATION-BASED STUDY

Por Liu, Yang, Tyler, Evan, Lustick, Martin, Klein, David, Walter, Kevin
Publicado no Neuro Oncol (2018)

ReCAP: Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care

Por Altomare, Ivy, Irwin, Blair, Zafar, Syed Yousuf, Houck, Kevin, Maloney, Bailey, Greenup, Rachel, Peppercorn, Jeffrey
Publicado no J Oncol Pract (2016)

Effort Required in Eligibility Screening for Clinical Trials

Por Penberthy, Lynne T., Dahman, Bassam A., Petkov, Valentina I., DeShazo, Jonathan P.
Publicado em 2012

Moving family interventions into the real world: What matters to oncology stakeholders?

Por Ratcliff, Chelsea G., Vinson, Cynthia A., Milbury, Kathrin, Badr, Hoda
Publicado no J Psychosoc Oncol (2018)

Major clinical research advances in gynecologic cancer in 2016: 10-year special edition

Por Suh, Dong Hoon, Kim, Miseon, Kim, Kidong, Kim, Hak Jae, Lee, Kyung-Hun, Kim, Jae-Weon
Publicado no J Gynecol Oncol (2017)

Cost Effectiveness of Gene Expression Profile Testing in Community Practice

Por Chandler, Young, Schechter, Clyde B., Jayasekera, Jinani, Near, Aimee, O’Neill, Suzanne C., Isaacs, Claudine, Phelps, Charles E., Ray, G. Thomas, Lieu, Tracy A., Ramsey, Scott, Mandelblatt, Jeanne S.
Publicado no J Clin Oncol (2018)

Preventing breast cancer in LMICs via screening and/or early detection: The real and the surreal

Por Dey, Subhojit
Publicado em 2014

Co-Development of Diagnostic Vectors to Support Targeted Therapies and Theranostics: Essential Tools in Personalized Cancer Therapy

Por Nicolaides, Nicholas C., O’Shannessy, Daniel J., Albone, Earl, Grasso, Luigi
Publicado em 2014